https://www.biospace.com/article/comparing-covid-19-vaccines-pfizer-biontech-moderna-astrazeneca-oxford-j-and-j-russia-s-sputnik-v/
輝瑞/BNT疫苗成為全球第一款研發成功的新冠肺炎疫苗,英國八日搶全球之開打後,美國食藥局(FDA)於十一日批准使用。外電...
陽明交大公衛所兼任教授、前衛生署副署長張鴻仁昨天在臉書上發文表示,世界衛生組織(WHO)已提出免疫橋接研究(Immuno bridging study)取代傳統三期臨床試驗的可能,可望成為國產疫苗是否夠通過緊急使用授權的依據
The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.